2m 2m 2m 2m 2m 2m 2m
AGENUS (AGEN)
NASDAQ
$3.25+$0.02 (+0.78%)
Price as of Jun 03, 2026 7:49 PM EDT- $145.7MMarket Cap
- -32.40%1-Year Change
- BiotechnologyIndustry
AGENUS (AGEN)
$3.25+$0.02 (+0.78%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 334,000 -99.68% | 103.5M -33.81% | 156.3M +59.47% | 98.0M -66.85% | |
Cost of Revenue | 1.0M +110.29% | 486,000 -84.38% | 3.1M -70.56% | 10.6M +204.55% | |
Gross Profit | -688,000 -100.67% | 103.0M -32.78% | 153.2M +75.18% | 87.5M -70.07% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -79.3M -48.99% | -155.5M -33.70% | -234.6M +25.65% | -186.7M +4.53% | |
Depreciation and Amortization Expense | 10.0M -25.06% | 13.3M -1.80% | 13.6M +95.62% | 6.9M +2.33% | |
Total Operating Expenses | 54.4M -24.33% | 71.9M -8.71% | 78.7M -2.80% | 81.0M +6.09% | |
Operating Profit | -20.2M -83.26% | -120.5M -24.49% | -159.5M -11.08% | -179.4M -796.89% | |
Interest Income | 345,000 -87.66% | 2.8M N/A | N/A N/A | N/A N/A | |
Interest Expense | -55.3M -53.01% | -117.6M +20.12% | -97.9M +58.29% | -61.9M -5.87% | |
Interest Income and Expense and Net | -54.9M -52.17% | -114.8M +17.26% | -97.9M +58.29% | -61.9M -5.87% | |
Total Nonoperating Income and Expense | -2.2M -138.08% | 5.8M +15,656.76% | 37,000 -99.71% | 12.6M +148.88% | |
Income before Taxes | -101,000 -99.96% | -227.4M -7.54% | -246.0M +11.66% | -220.3M +812.65% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | 234,000 -88.14% | 2.0M N/A | 0 -100.00% | 6.1M N/A | |
Net Income | -3.1M -98.67% | -232.3M -9.78% | -257.4M +11.61% | -230.7M +703.01% | |
Net Income from Continuing Operations Applicable to Common | -101,000 -99.96% | -227.4M -7.54% | -246.0M +11.66% | -220.3M +812.65% | |
Basic EPS and Net Income | 0.00 +100.00% | -10.59 +1,434.78% | -0.69 -11.54% | -0.78 +609.09% | |
Diluted EPS and Net Income | 0.00 +100.00% | -10.59 +1,434.78% | -0.69 -11.54% | -0.78 +609.09% | |
Basic Weighted Average Shares | 29.7M +38.47% | 21.5M +5,899.90% | 357,889 +27.03% | 281,743 +23.08% | |
Diluted Weighted Average Shares | 29.7M +38.47% | 21.5M +5,899.90% | 357,889 +27.03% | 281,743 +23.08% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.0M -92.59% | 40.4M -46.87% | 76.1M -57.40% | 178.7M -38.80% | |
Short-Term Investments | N/A N/A | N/A N/A | 14.7M 0.00% | 14.7M -2.05% | |
Cash and Cash Equivalents and Short-Term Investments | 3.0M -92.59% | 40.4M -55.46% | 90.8M -53.04% | 193.4M -37.00% | |
Total Current Assets | 133.4M +192.79% | 45.6M -59.46% | 112.4M -47.25% | 213.1M -35.80% | |
Accumulated Depreciation | 47.5M -34.57% | 72.6M +17.13% | 61.9M +14.55% | 54.1M +7.00% | |
Property and Plant and Equipment and Net | 15.5M -87.12% | 120.1M -9.99% | 133.4M +0.30% | 133.0M +121.59% | |
Total Long-Term Assets | 3.3M -43.32% | 5.8M -37.51% | 9.3M +109.66% | 4.5M -53.31% | |
Total Assets | 226.8M +0.23% | 226.3M -27.92% | 313.9M -24.09% | 413.6M -11.25% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 44.7M +1,555.11% | 2.7M +1,747.95% | 146,000 -74.61% | 575,000 -21.02% | |
Total Current Liabilities | 323.5M +46.11% | 221.4M -13.48% | 255.9M +35.43% | 189.0M +20.40% | |
Total Long-Term Debt | 0 -100.00% | 30.5M +138.67% | 12.8M +1.46% | 12.6M -1.86% | |
Total Long-Term Liabilities | 259,000 -64.91% | 738,000 -86.38% | 5.4M -60.80% | 13.8M +776.73% | |
Total Liabilities | 333.6M +20.89% | 276.0M -13.33% | 318.4M +26.21% | 252.3M +26.74% | |
Retained Earnings | -2.2B -0.005% | -2.2B +11.62% | -2.0B +14.37% | -1.7B +14.77% | |
Total Stockholders Equity | -271.1M -16.93% | -326.4M +103.57% | -160.3M +161.65% | -61.3M -277.93% | |
Total Shares Outstanding | 35.3M +49.44% | 23.6M -94.01% | 394.4M +29.06% | 305.6M +18.95% | |
Cash Flow | |||||
Cash from Operating Activities | -77.2M -51.24% | -158.3M -29.39% | -224.2M +27.84% | -175.4M -1,828.66% | |
Capital Expenditures | 6,000 -98.96% | 576,000 -94.21% | 10.0M -81.24% | 53.1M +56.92% | |
Cash from Investing Activities | 1.2M +4,322.22% | 27,000 -99.21% | 3.4M +110.12% | -33.6M -22.11% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 36.6M -70.21% | 122.8M +2.48% | 119.9M +25.08% | 95.8M -57.46% | |
Financials Ratio | |||||
Gross Margin | -205.99% -306.96% | 99.53% +1.55% | 98.01% +9.85% | 89.22% -9.72% | |
Operating Margin | -6,038.62% +5,085.92% | -116.44% +14.08% | -102.07% -44.24% | -183.04% -2,201.97% | |
Return on Assets | -1.36% -98.42% | -86.00% +21.51% | -70.78% +34.94% | -52.45% +521.28% | |
Return on Equity | 1.03% -98.92% | 95.45% -58.92% | 232.33% -86.48% | 1,718.88% +4,963.52% | |
Revenue Growth | -99.68% +194.81% | -33.81% -156.86% | 59.47% +188.96% | -66.85% -128.40% | |
Current Ratio | 0.41 +100.44% | 0.21 -53.15% | 0.44 -61.05% | 1.13 -46.68% | |
Cash Ratio | 0.009 -94.91% | 0.18 -38.60% | 0.30 -68.55% | 0.95 -49.16% | |
Debt-to-Equity Ratio | -0.16 +62.11% | -0.10 +26.21% | -0.08 -62.51% | -0.21 -154.56% | |
Debt-to-Assets Ratio | 0.20 +34.31% | 0.15 +256.69% | 0.04 +29.25% | 0.03 +9.28% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow